Application of Global Leadership Initiative on Malnutrition standard in patients with maintenance hemodialysis
-
摘要:目的 探讨全球(营养)领导层倡议营养不良(GLIM)标准在维持性血液透析(MHD)患者营养状况评估中的应用价值。方法 选择MHD患者102例,同时使用GLIM和主观整体评估(SGA)进行营养状况评估,比较GLIM与SGA的一致性。采集MHD患者一般病史、实验室检测等,分析上述指标与GLIM的相关性。结果 MHD患者采用SGA与GLIM评价,营养不良发生率均较高(48.0%和45.1%)。2种方法在营养不良定性评估的一致性良好(Kappa值0.782);在营养不良分级评估的一致性一般(Kappa值0.595)。根据GLIM标准,体质量指数(BMI)、白蛋白(ALB)、甘油三酯(TG)、总胆固醇(TC)及血肌酐(Scr)较低,女性且年长者,更容易被识别为营养不良。其中,BMI、ALB是GLIM的独立影响因素。结论 GLIM标准与传统方法相比具有较好的一致性,且和多项营养指标存在相关性,可应用于MHD患者的营养评估。
-
关键词:
- 全球(营养)领导层倡议营养不良 /
- 主观整体评估 /
- 维持性血液透析 /
- 营养不良
Abstract:Objective To explore the application value of Global Leadership Initiative on Malnutrition (GLIM) standard in assessment of nutritional status of patients with maintenance hemodialysis (MHD).Methods A total of 102 patients with MHD were selected and conducted with both GLIM and Subjective Global Assessment (SGA) for assessment of nutritional status, and the consistency between GLIM and SGA was compared. General medical history and laboratory tests of MHD patients were collected, and correlations between these indexes and GLIM were analyzed.Results The incidence of malnutrition was higher in MHD patients evaluated by SGA and GLIM (48.0% and 45.1%). There was a good consistency of two methods in qualitative evaluation of malnutrition (Kappa value was 0.782). In the assessment of the severity of malnutrition, the consistency of two methods was moderate (Kappa value was 0.595). According to GLIM standard, cases with lower body mass index (BMI), albumin (ALB), triglyceride (TG), total cholesterol (TC) and serum creatinine (Scr) and older female cases were more likely to be identified as malnutrition, and BMI and ALB were the independent influencing factors of GLIM.Conclusion Compared with conventional methods, GLIM standard has a better consistency and is correlated with multiple nutritional indexes, which can be applied to the nutritional evaluation of MHD patients. -
-
表 1 GLIM营养不良相关因素分析(x±s)[n(%)]
指标 GLIM营养良好组(n=56) GLIM营养不良组(n=46) t/Z/χ2值 P值 女性 16(28.57) 25(54.35)** 6.980 0.008 年龄/岁 55.79±11.45 60.70±12.99* -2.027 0.045 透析龄/个月 47.50±60.75 38.00±104.00 -0.259 0.796 体质量指数/(kg/m2) 24.37±2.90 19.91±2.64** 8.034 < 0.001 白蛋白/(g/L) 41.10±3.30 38.20±5.35** -4.305 < 0.001 血红蛋白/(g/L) 107.77±18.14 102.46±17.92 1.415 0.161 血肌酐/(μmol/L) 918.17±295.42 715.02±336.11** 3.045 0.003 尿素氮/(mmol/L) 21.02±7.70 18.81±7.27 1.375 0.173 谷氨酸-丙酮酸转氨酶/(U/L) 9.30±7.00 11.00±12.00 -1.200 0.197 天门冬氨酸转氨酶/(U/L) 12.00±6.50 14.35±9.00 -1.695 0.090 总胆固醇/(mmol/L) 4.31±1.10 3.78±0.85* 2.058 0.044 甘油三酯/(mmol/L) 1.96±1.60 1.18±0.61** -3.029 0.002 低密度脂蛋白/(mmol/L) 2.12±0.79 2.06±0.69 0.308 0.759 高密度脂蛋白/(mmol/L) 0.92±0.29 1.06±0.43 -1.554 0.162 甲状旁腺激素/(pg/ml) 374.05±462.55 284.90±291.90 -1.491 0.136 C反应蛋白/(mg/L) 5.58±8.55 4.06±9.23 -0.731 0.465 糖尿病肾病 12(21.43) 15(32.61) 1.622 0.203 参与工作 13(23.21) 6(13.04) 1.724 0.189 睡眠障碍 23(41.07) 25(54.35) 1.787 0.181 GLIM: 全球(营养)领导层倡议营养不良。与GLIM营养良好组比较, *P < 0.05, **P < 0.01。 表 2 SGA评估不同营养状况下的差异指标(x±s)[n(%)]
指标 SGA营养良好组(n=53) SGA营养不良组(n=49) t/Z/χ2值 P值 年龄/岁 55.34±11.86 60.88±12.35* -2.310 0.023 体质量指数/(kg/m2) 24.26±3.18 20.31±2.72** 6.711 < 0.001 白蛋白/(g/L) 41.25±2.80 38.30±4.90** -4.229 < 0.001 血肌酐/(μmol/L) 924.23±309.87 722.60±317.96** 3.042 0.003 甘油三酯/(mmol/L) 2.02±1.58 1.21±0.76** -3.031 0.002 参与工作 14(26.42) 5(10.20)* 4.414 0.036 睡眠障碍 19(35.85) 29(59.18)* 5.565 0.018 SGA: 主观整体评估。与SGA营养良好组比较, *P < 0.05, **P < 0.01。 表 3 GLIM营养不良相关因素logistic回归分析
指标 B SE Wald df P Exp(B) 95%Cl. for Exp(B) 下限 上限 体质量指数/(kg/m2) -0.744 0.225 10.965 1 0.001** 0.475 0.306 0.738 白蛋白/(g/L) -0.384 0.136 7.995 1 0.005** 0.681 0.522 0.889 将GLIM组间存在差异的指标及MHD潜在营养不良影响因素共同纳入进行回归分析, **P < 0.01。 -
[1] 中国医师协会肾脏内科医师分会, 中国中西医结合学会肾脏疾病专业委员会营养治疗指南专家协作组. 中国慢性肾脏病营养治疗临床实践指南(2021版)[J]. 中华医学杂志, 2021, 101(8): 539-559. [2] SILVA R E, SIMOES-E-SILVA A C, MIRANDA A S, et al. Potential Role of Nutrient Intake and Malnutrition as Predictors of Uremic Oxidative Toxicity in Patients with End-Stage Renal Disease[J]. Oxid Med Cell Longev, 2019: 1-12.
[3] 刘承宇, 杨鑫, 崔红元, 等. 结直肠癌患者GLIM标准下的营养不良对临床结局的影响[J]. 中华临床营养杂志, 2020, 28(6): 340-345. doi: 10.3760/cma.j.cn115822-20201217-00275 [4] 关珂, 李小萌, 张献娜, 等. 郑州某三甲医院营养风险及营养不良(按GLIM)患病率(7247例横断面调查)[J]. 中华临床营养杂志, 2020, 28(5): 275-282. [5] ZHANG X, TANG M, ZHANG Q, et al. The GLIM criteria as an effective tool for nutrition assessment and survival prediction in older adult cancer patients[J]. Clin Nutr, 2021, 40(3): 1224-1232. doi: 10.1016/j.clnu.2020.08.004
[6] 于恺英, 杨韵, 石汉平. 全球领导人营养不良倡议(GLIM)标准及其推广应用[J]. 营养学报, 2020, 42(3): 209-214. doi: 10.3969/j.issn.0512-7955.2020.03.001 [7] CEDERHOLM T, JENSEN G L, CORREIA M, et al. GLIM criteria for the diagnosis of malnutrition-A consensus report from the global clinical nutrition community[J]. Clin Nutr, 2019, 38(1): 1-9. doi: 10.1016/j.clnu.2018.08.002
[8] CUPPARI L, MEIRELES M S, RAMOS C I, et al. Subjective global assessment for the diagnosis of protein-energy wasting in nondialysis-dependent chronic kidney disease patients[J]. J Ren Nutr, 2014, 24(6): 385-389. doi: 10.1053/j.jrn.2014.05.004
[9] 周新, 张勍烨, 张利平, 等. 维持性血液透析患者营养状况与死亡风险的相关性探讨[J]. 武警医学, 2020, 31(11): 955-960. doi: 10.3969/j.issn.1004-3594.2020.11.009 [10] IKIZLER T A, BURROWES J D, BYHAM-GRAY L D, et al. KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update[J]. Am J Kidney Dis, 2020, 76(3 Suppl 1): S1-S107.
[11] CONTRERAS-BOLIVAR V, SANCHEZ-TORRALVO F J, RUIZ-VICO M, et al. GLIM Criteria Using Hand Grip Strength Adequately Predict Six-Month Mortality in Cancer Inpatients[J]. Nutrients, 2019, 11(9): 1-13.
[12] 陈曦, 杨剑, 林晓倩, 等. 重庆某三甲教学医院用NRS 2002及诊断营养不良(GLIM)标准对癌症患者营养风险和营养不良患病率调查研究初探[J]. 中华临床营养杂志, 2020, 28(4): 201-206. doi: 10.3760/cma.j.cn115822-20200509-00127 [13] 张楠, 郭志勇. 微炎症因子在监测血液透析患者心血管并发症中的作用研究进展[J]. 中华肾病研究电子杂志, 2021, 10(1): 47-50. doi: 10.3877/cma.j.issn.2095-3216.2021.01.010 [14] SAHATHEVAN S, KHOR B H, NG H M, et al. Understanding Development of Malnutrition in Hemodialysis Patients: A Narrative Review[J]. Nutrients, 2020, 12(10): 1-31.
[15] PENG H, AOIEONG C, TOU T, et al. Clinical assessment of nutritional status using the modified quantified subjective global assessment and anthropometric and biochemical parameters in patients undergoing hemodialysis in Macao[J]. J Int Med Res, 2021, 49(9): 1-11.
[16] ANTON-PEREZ G, SANTANA-DEL-PINO A, HENRIQUEZ-PALOP F, et al. Diagnostic Usefulness of the Protein Energy Wasting Score in Prevalent Hemodialysis Patients[J]. J Ren Nutr, 2018, 28(6): 428-434. doi: 10.1053/j.jrn.2018.05.002
[17] GEROGIANNI G, KOUZOUPIS A, GRAPSA E. A holistic approach to factors affecting depression in haemodialysis patients[J]. Int Urol Nephrol, 2018, 50(8): 1467-1476. doi: 10.1007/s11255-018-1891-0
[18] RAJKUMAR R, BAUMGART A, MARTIN A, et al. Perspectives on ability to work from patients' receiving dialysis and caregivers: analysis of data from the global SONG initiative[J]. J Nephrol, 2021(7): 1-12.
-
期刊类型引用(10)
1. 徐颖. 多层螺旋CT联合核磁共振成像增强扫描在胰腺癌及慢性胰腺炎鉴别诊断中的价值分析. 大医生. 2024(01): 127-129 . 百度学术
2. 高成强,毕司星,李立新. CT平扫联合增强扫描在胰腺癌诊断中的应用价值. 影像研究与医学应用. 2024(02): 31-33 . 百度学术
3. 侯胜楠. CT、MRI增强扫描对胰腺癌与慢性胰腺炎的鉴别诊断价值. 中华养生保健. 2024(07): 176-180 . 百度学术
4. 柳群力,朱鸷翔. CT联合分泌型卷曲受体蛋白4及可溶性生长刺激表达基因2蛋白对恶性胆道梗阻患者术后并发胰腺炎的诊断价值. 实用临床医药杂志. 2024(05): 59-62+67 . 本站查看
5. 郑北. 联合应用CT、MRI增强扫描鉴别诊断胰腺癌与慢性胰腺炎的价值. 中国医疗器械信息. 2024(08): 12-14+25 . 百度学术
6. 曹中立. 多层螺旋CT在胰腺癌术前评估及诊断中的应用价值. 影像研究与医学应用. 2024(10): 132-134 . 百度学术
7. 杨懿,黄新蓉. MRI与CT检查诊断急性胰腺炎的价值比较研究. 影像研究与医学应用. 2024(14): 135-137+140 . 百度学术
8. 董源涛,尚金红,袁燕丽. MRI联合CT在胰腺肿瘤中的诊断价值. 影像研究与医学应用. 2024(16): 137-139 . 百度学术
9. 游红莲,闫明艳,褚千琨,王芳芳,陈文晶,于根建,王静. 隐匿性小胰腺癌并急性胰腺炎与单纯性急性胰腺炎的CT对比分析. 临床误诊误治. 2024(17): 63-68 . 百度学术
10. 刘强. 多层螺旋CT与MRI扫描鉴别诊断胰腺癌和胰腺炎的有效性探讨. 影像研究与医学应用. 2024(19): 24-26 . 百度学术
其他类型引用(1)
计量
- 文章访问数: 236
- HTML全文浏览量: 145
- PDF下载量: 19
- 被引次数: 11